Clinical Evaluation of an Aerosol Protective Intubation Device on Videolaryngoscopic Intubation Difficulty - Trial NCT04865081
Access comprehensive clinical trial information for NCT04865081 through Pure Global AI's free database. This phase not specified trial is sponsored by Maisonneuve-Rosemont Hospital and is currently status unknown. The study focuses on Intubation. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Maisonneuve-Rosemont Hospital
Timeline & Enrollment
N/A
Apr 19, 2021
Jul 01, 2021
Primary Outcome
Intubation time
Summary
The VACCIN box, an anti-aerosol intubation box for potential use on COVID-19 (SARS-CoV-2)
 positive patients, was designed in order to reduce the transmission risk to healthcare
 workers. This study will compare the safety and the ease of use of the VACCIN box to a
 standard intubation in healthy participants undergoing elective surgery. It is expected that
 intubation times and success rate of intubation in the same circumstances will be similar
 with and without the use of the VACCIN box.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04865081
Device Trial